Orion

Orion Intangible Assets

The Intangible Assets of Orion (271560.KS) as of Nov 2, 2026 is 44.97 B KRW. In the previous year, Intangible Assets was 29.91 B KRW — a change of 50.34% (higher).

Intangible Assets

44.97 BKRW

YoY

50.34%

Last updated:

Intangible Assets of Orion is 2024 44.97 B KRW. Intangible Assets of Orion was 2023 29.91 B KRW. It decreases by 50.34% higher compared to the previous year.

The Orion Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
29.63 B KRW
Jan 1, 2018
28.97 B KRW
Jan 1, 2019
31.81 B KRW
Jan 1, 2020
32.53 B KRW
Jan 1, 2021
33.15 B KRW
Jan 1, 2022
31.16 B KRW
Jan 1, 2023
29.91 B KRW
Jan 1, 2024
44.97 B KRW
The Orion Intangible Assets history
YEARIntangible AssetsYoY
44.97 BKRW+50.34%
29.91 BKRW-3.99%
31.16 BKRW-6.02%
33.15 BKRW+1.90%
32.53 BKRW+2.26%
31.81 BKRW+9.81%
28.97 BKRW-2.21%
29.63 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Orion Stock analysis

What does Orion do? Orion Corp is a Finnish company that operates in the pharmaceutical industry. The company was founded in 1917 and is headquartered in Espoo, Finland. Orion Corp specializes in the development, manufacturing, and marketing of medications, as well as the diagnosis and treatment of diseases. As one of the leading pharmaceutical companies in Finland, Orion Corp is dedicated to researching and developing medications and medical devices to help doctors and their patients worldwide improve their quality of life. Orion Corp's business model focuses on selling prescription and over-the-counter medications, as well as manufacturing generic medications. Additionally, the company is involved in the diagnosis and treatment of diseases such as Parkinson's, cancer, and asthma. The company's main business is centered around three main divisions: pharmaceuticals, diagnostics, and animal health. Within these divisions, Orion Corp has various business areas. In the pharmaceutical division, the focus is on developing medications to combat Parkinson's, cancer, and asthma. The company has a strong product range of Parkinson's treatments that can alleviate symptoms and slow the progression of the disease. Furthermore, the company is involved in the development of cancer medications that can inhibit the growth of cancer cells. Orion Corp is also a key player in asthma treatment. The company produces medications that expand the airways and make breathing easier. In the diagnostics division, Orion Corp's main business is the development and manufacturing of diagnostic devices for diseases such as lung cancer and asthma, as well as products for monitoring blood sugar and cholesterol. Animal health is another important business area for Orion Corp. The company manufactures medications and accessories for animal health and offers a variety of products to veterinarians and breeders. These include, for example, animal vaccines or hormone preparations to increase fertility in animals. Orion's production facilities are located in six countries, including Finland, Germany, France, Russia, the USA, and India. Production within the company primarily takes place in Finland. In addition to manufacturing medications and medical devices, Orion Corp is also a leading producer and developer of raw materials and intermediates for pharmaceutical applications worldwide. In summary, Orion Corp offers a wide range of products and services in the health and animal health fields using the latest scientific knowledge and technologies. The company remains committed to continuously expanding its product and service portfolio and providing patients worldwide with high-quality and effective medications that positively impact their lives. Orion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orion stock

Intangible Assets of Orion is 44.97 B KRW in 2024.

Intangible Assets of Orion changed from 29.91 B KRW to 44.97 B KRW, representing a 50.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Orion since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Orion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Orion

All Key Metrics — Orion